Le Lézard
Classified in: Health

Women's Excellence Offers Comprehensive Hereditary Cancer Testing in Recognition of Breast Cancer Awareness Month


DETROIT, Oct. 19, 2020 /PRNewswire-PRWeb/ -- While most cancers happen by chance due to a variety of factors, about 10% of the time, cancer is linked to a single change in a gene, or mutation, that has been passed down from family members. This is referred to as hereditary cancer. A person who has inherited a gene mutation associated with hereditary cancer will not necessarily get cancer, but he or she is at a higher risk than those without a gene mutation. People with a mutation in either the BRCA1 or BRCA2 gene have risks of up to 87% for developing breast cancer and up to 44% for developing ovarian cancer by age 70. Women's Excellence is pleased to offer hereditary cancer testing (genetic testing) to help women identify gene mutations that may lead to certain cancers.

Dr. Jonathan Zaidan, MD, FACOG, President of Women's Excellence makes preventative care a top priority for patients at Women's Excellence.

"We've all heard the saying 'Knowledge is Power,' and that is exactly the mantra behind hereditary cancer testing," says Zaidan. "Depending on your results, hereditary cancer testing provides us the information we need to create a proactive plan of care. For example, if a patient is positive for certain gene mutations, we may be able to overcome insurance barriers to allow for screening at a much earlier age. This quick and efficient tool can help save lives, and we're proud to offer this advanced service at Women's Excellence!"

Hereditary cancer testing (genetic testing) is a simple in-office blood test that is analyzed by a specialized laboratory.

To be eligible for genetic testing, patients need to identify their hereditary cancer risk. Women's Excellence offers a quick risk assessment survey at https://www.womensexcellence.com/risk-assessment/. Once the assessment has been completed, Women's Excellence will contact you within 72 hours to notify you on your eligibility for genetic testing.

About Women's Excellence
Women's Excellence is the most comprehensive obstetric and gynecologic office in Michigan. Additionally, they specialize in menopause, weight control, bladder control, endometriosis, robotic surgery, oncology, and midwifery services. Women's Excellence is committed to staying at the forefront of innovation with cutting edge technologies utilizing robotic surgery and minimally invasive surgical options when possible. The knowledgeable, compassionate physicians and healthcare providers of Women's Excellence focus on patient-centered processes to deliver the highest quality of care. They are affiliated with most insurances. They offer seamless medical record access via a state-of-the-art patient portal and use the latest technology for record keeping and sharing, making the patient experience easier and more efficient. Women's Excellence is taking new patients and is conveniently located throughout southeastern Michigan in Clarkston, Lake Orion, Lapeer, Rochester, Royal Oak, and West Bloomfield. Women's Excellence is also a proud partner of Detroit's longstanding radio network, WJR 760AM, providing expert women's health news and information. For more information, visit http://www.WomensExcellence.com.

 

SOURCE Women's Excellence in Obstetrics and Gynecology


These press releases may also interest you

at 08:00
DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , a healthcare technology company focused on brain health using AI, today announced a clinical validation milestone of the BRAIN AGE® Brain Health AI Platform ("BRAIN AGE®"), a world-first...

at 08:00
Autism Speaks Canada, a national charity dedicated to creating an inclusive Canada for all individuals with autism throughout their lifespan, announced the appointment of Tracy Culleton as its Executive Director. An extensive search was conducted by...

at 08:00
Tilray Brands, Inc. ("Tilray") , a premier global leader in the cannabis-lifestyle and consumer packaged goods industry, celebrated 420 with an unprecedented display of community and craftsmanship, with over 20,000 guests attending Tilray's 420...

at 07:58
AMBOSS, the leading clinical resource for residents, proudly announces its recent acquisition of NEJM Knowledge+, a learning and assessment tool for clinicians created by NEJM Group, publishers of the New England Journal of Medicine and other...

at 07:56
RTI International today announced that Early Check, a groundbreaking research study that provides free voluntary health tests for newborns up to four weeks old in North Carolina, has chosen Revvity, Inc. to conduct genome sequencing for the study...

at 07:55
AMRA Medical, a health informatics and precision medicine company that is pioneering body composition research through gold-standard MRI-based analysis platforms, in collaboration with Linköping University, is pleased to announce the completion of...



News published on and distributed by: